Idexx Laboratories IDXX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.06B+19.3% | $887.87M+5.1% | $845.04M+24.4% | $679.09M-8.8% | ||
| $145.18M+11.7% | $129.94M+13.1% | $114.91M+2.7% | $111.9M+7.0% | ||
| $60.01M-0.5% | $60.3M+0.9% | $59.74M+20.0% | $49.77M+31.8% | ||
| $131.2M— | —— | -$48.31M-30.9% | -$36.89M— | ||
| —— | —— | $1.48M-36.7% | $2.35M— | ||
| $8.43M+22.7% | $6.87M+23.7% | $5.55M-4.8% | $5.83M— | ||
| —— | —— | —— | —— | ||
| —— | $28M— | —— | $121.73M+130% | ||
| —— | —— | —— | $3.47M— | ||
| $5.03M+242% | $1.47M— | —— | $2.65M+1.0% | ||
| $1.18B+27.2% | $929M+2.5% | $906.51M+66.9% | $542.98M-28.1% | ||
| $124.68M+3.1% | $120.92M-9.5% | $133.63M-10.2% | $148.84M+24.5% | ||
| —— | —— | $0— | —— | ||
| —— | —— | —— | —— | ||
| -$136.24M+34.2% | -$207.06M-65.3% | -$125.25M+35.9% | -$195.35M+33.3% | ||
| $1.22B+45.4% | $837.03M+1,064% | $71.92M-91.2% | $819.71M+9.8% | ||
| $93.36M+110% | $44.49M-5.4% | $47.03M+31.6% | $35.75M-23.2% | ||
| $7.24M-31.3% | $10.53M+5.6% | $9.98M-5.9% | $10.61M-32.0% | ||
| -$1.16B-32.7% | -$878.07M-98.7% | -$442M-19.2% | -$370.94M+46.8% | ||
| —— | -$9.53M— | —— | —— | ||
| —— | -$169.82M-150% | $341.39M— | —— | ||
| —— | —— | $1.48M-36.7% | $2.35M— | ||
| $8.43M+22.7% | $6.87M+23.7% | $5.55M-4.8% | $5.83M— | ||
| —— | —— | —— | —— | ||
| —— | —— | $0— | —— | ||
| $93.36M+110% | $44.49M-5.4% | $47.03M+31.6% | $35.75M-23.2% | ||
| —— | $0+100% | -$329M— | —— | ||
| $250M— | $0— | $0— | —— | ||
| —— | —— | —— | —— | ||
| $2.74M+76.1% | $1.56M-81.4% | $8.38M— | —— | ||
| $250M— | $0— | $0— | —— | ||
| $1.06B+30.8% | $808.08M+4.6% | $772.88M+96.1% | $394.15M-38.0% | ||
| $1.06B+30.8% | $808.08M+4.6% | $772.88M+96.1% | $394.15M-38.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Idexx Laboratories generate?
- Idexx Laboratories (IDXX) generated $1.2B in operating cash flow over the trailing twelve months.
- What is Idexx Laboratories's free cash flow?
- After $126.6M of capital expenditures, Idexx Laboratories's free cash flow was $1.1B over the trailing twelve months, up 27.8% year over year.
- Where does Idexx Laboratories's cash flow data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
